The prevalence of hepatitis B virus, human T‐lymphotropic virus and human immunodeficiency virus in patients receiving blood transfusions in South Africa

Ähnliche Einträge

• Risk factors for incident human immunodeficiency virus infection in South African blood donors
  von: Avril Swarts, et al.
  Veröffentlicht: (2025)
• The importance of confirmatory assays in testing blood donors for human T‐cell lymphotropic virus
  von: Marina Lobato Martins, et al.
  Veröffentlicht: (2024)
• Trends in donor infection profiles and residual risks of transfusion‐transmitted human immunodeficiency virus, hepatitis C virus and hepatitis B virus after the implementation of universal mini‐pool nucleic acid testing in Taiwan
  von: Wen‐Jie Liu, et al.
  Veröffentlicht: (2025)
• Comment on ‘Comparing specificity and seroconversion sensitivity among major blood screening assays for human immunodeficiency virus and viral hepatitis’
  von: Ramune Sepetiene, et al.
  Veröffentlicht: (2026)
• Cost‐effectiveness of a hypothetical assay to evaluate stored blood quality prior to transfusion
  von: Melissa C. Caughey, et al.
  Veröffentlicht: (2025)